- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN-MAN.2: 3 residues within 4Å:- Chain A: N.37, T.317
- Ligands: NAG.6
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.3: 7 residues within 4Å:- Chain A: N.164, T.166, I.241, M.243
- Chain E: S.218, P.220, L.221
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain E- Hydrophobic interactions: A:I.241
- Hydrogen bonds: E:L.221
NAG-NAG-BMA-MAN-MAN.11: 3 residues within 4Å:- Chain C: N.37, T.317
- Ligands: NAG.15
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.12: 7 residues within 4Å:- Chain A: S.218, P.220, L.221
- Chain C: N.164, T.166, I.241, M.243
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:L.221
- Hydrophobic interactions: C:I.241
NAG-NAG-BMA-MAN-MAN.20: 3 residues within 4Å:- Chain E: N.37, T.317
- Ligands: NAG.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.21: 7 residues within 4Å:- Chain C: S.218, P.220, L.221
- Chain E: N.164, T.166, I.241, M.243
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain E- Hydrogen bonds: C:L.221
- Hydrophobic interactions: E:I.241
- 3 x NAG- NAG- BMA- MAN- BMA: beta-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-BMA.4: 5 residues within 4Å:- Chain A: P.283, N.284, V.296, N.297
- Chain B: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-BMA.13: 5 residues within 4Å:- Chain C: P.283, N.284, V.296, N.297
- Chain D: E.69
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-BMA.22: 5 residues within 4Å:- Chain E: P.283, N.284, V.296, N.297
- Chain F: E.69
No protein-ligand interaction detected (PLIP)- 3 x NGS- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranose
NGS-GAL-SIA.5: 13 residues within 4Å:- Chain A: Y.97, G.133, R.134, S.135, G.136, W.152, T.154, H.182, E.189, K.192, L.193, Q.225, G.227
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:Q.225, A:Q.225, A:Y.97, A:R.134, A:R.134, A:G.136, A:H.182, A:Q.225, A:Q.225
- Salt bridges: A:K.192
- Hydrophobic interactions: A:L.193
NGS-GAL-SIA.14: 13 residues within 4Å:- Chain C: Y.97, G.133, R.134, S.135, G.136, W.152, T.154, H.182, E.189, K.192, L.193, Q.225, G.227
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:Q.225, C:Q.225, C:Y.97, C:R.134, C:R.134, C:G.136, C:H.182, C:Q.225, C:Q.225
- Salt bridges: C:K.192
- Hydrophobic interactions: C:L.193
NGS-GAL-SIA.23: 13 residues within 4Å:- Chain E: Y.97, G.133, R.134, S.135, G.136, W.152, T.154, H.182, E.189, K.192, L.193, Q.225, G.227
8 PLIP interactions:8 interactions with chain E- Hydrogen bonds: E:Q.225, E:Q.225, E:Y.97, E:R.134, E:R.134, E:G.136, E:H.182, E:Q.225, E:Q.225
- Salt bridges: E:K.192
- Hydrophobic interactions: E:L.193
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 4 residues within 4Å:- Chain A: N.21, T.23, N.37
- Ligands: NAG-NAG-BMA-MAN-MAN.2
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.21
NAG.15: 4 residues within 4Å:- Chain C: N.21, T.23, N.37
- Ligands: NAG-NAG-BMA-MAN-MAN.11
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.21
NAG.24: 4 residues within 4Å:- Chain E: N.21, T.23, N.37
- Ligands: NAG-NAG-BMA-MAN-MAN.20
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.21
- 9 x SO4: SULFATE ION(Non-functional Binders)
SO4.7: 2 residues within 4Å:- Chain A: R.320
- Chain B: A.7
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:R.320
SO4.8: 4 residues within 4Å:- Chain A: R.134, R.140, D.144, S.145
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.145, A:S.145
- Salt bridges: A:R.134, A:R.140
SO4.9: 5 residues within 4Å:- Chain B: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.15, B:G.16
- Salt bridges: B:R.25
SO4.16: 2 residues within 4Å:- Chain C: R.320
- Chain D: A.7
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:R.320
SO4.17: 4 residues within 4Å:- Chain C: R.134, R.140, D.144, S.145
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:S.145, C:S.145
- Salt bridges: C:R.134, C:R.140
SO4.18: 5 residues within 4Å:- Chain D: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:E.15, D:G.16
- Salt bridges: D:R.25
SO4.25: 2 residues within 4Å:- Chain E: R.320
- Chain F: A.7
1 PLIP interactions:1 interactions with chain E- Salt bridges: E:R.320
SO4.26: 4 residues within 4Å:- Chain E: R.134, R.140, D.144, S.145
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:S.145, E:S.145
- Salt bridges: E:R.134, E:R.140
SO4.27: 5 residues within 4Å:- Chain F: G.13, W.14, E.15, G.16, R.25
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:E.15, F:G.16
- Salt bridges: F:R.25
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Collins, P.J. et al., Recent Evolution of Equine Influenza and the Origin of Canine Influenza. Proc.Natl.Acad.Sci.USA (2014)
- Release Date
- 2014-07-23
- Peptides
- HA1: ACE
HA2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- BMA: beta-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NGS- GAL- SIA: N-acetyl-alpha-neuraminic acid-(2-3)-beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-6-O-sulfo-beta-D-glucopyranose
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Collins, P.J. et al., Recent Evolution of Equine Influenza and the Origin of Canine Influenza. Proc.Natl.Acad.Sci.USA (2014)
- Release Date
- 2014-07-23
- Peptides
- HA1: ACE
HA2: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B